文献速递免疫规划传染病防控与疫情报告

疫苗接种对SARS-CoV-2感染青少年长新冠的预防效果

Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection.
PubMed 文献 · Vaccine · 2025-11-01

研究纳入美国60余家医疗和社区机构的SARS-CoV-2感染青少年,比较感染前6个月内接种疫苗者(n=724)与未接种者(n=507)的长新冠风险,两组按性别、感染日期和入组日期匹配。接种组长新冠风险较未接种组低36%(95%CI,17%,50%)。结论认为疫苗接种可降低长新冠风险,支持将疫苗接种作为预防长新冠的策略。

要点

  • 感染前6个月内接种COVID-19疫苗的青少年长新冠风险较未接种者低36%(95%CI,17%,50%)。
  • 接种组(n=724)与未接种组(n=507)按性别、感染日期和入组日期匹配。
  • 长新冠采用长新冠研究指数定义。

核心结论

  • 疫苗接种可降低SARS-CoV-2感染青少年的长新冠风险,支持将疫苗接种作为预防长新冠的策略。

研究设计与样本

  • 研究纳入美国60余家医疗和社区机构的12-17岁SARS-CoV-2感染青少年,暴露为感染前6个月内接种任何COVID-19疫苗,结局为采用长新冠研究指数定义的长新冠。
  • 接种组(n=724)与未接种组(n=507)按性别、感染日期和入组日期匹配。

主要发现

  • 接种组长新冠风险较未接种组低36%(95%CI,17%,50%)。

临床怎么用

  • 作者认为,鉴于长新冠对青少年健康和福祉的深远影响及该发育阶段治疗手段有限,本研究通过证明重要的二级预防效果,支持将疫苗接种作为预防长新冠的策略。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In adolescents (12-17 years), it is unknown whether COVID-19 vaccination reduces progression from COVID-19 to Long COVID (LC) beyond preventing SARS-CoV-2 infection. We assessed the effect of vaccination among SARS-CoV-2 infected adolescents. METHODS AND RESULTS: Participants were recruited from over 60 US healthcare and community settings. The exposure was any COVID-19 vaccination 6 months prior to infection. The outcome was LC defined using the LC research index. Vaccinated (n = 724) and unvaccinated (n = 507) adolescents were matched on sex, infection date, and enrollment date. The risk of LC was 36 % lower (95 % CI, 17 %, 50 %) in vaccinated compared to unvaccinated participants. CONCLUSIONS: Vaccination reduces the risk of LC. Given the profound impact LC can have on the health and well-being of adolescents and the limited availability of treatments during this developmental stage, this supports vaccination as a strategy for preventing LC by demonstrating an important secondary prevention effect.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Thaweethai T, Gross RS, Pant DB, et al. Preventive effect of vaccination on long COVID in adolescents with SARS-CoV-2 infection. Vaccine. 2025. PMID: 41176968. doi:10.1016/j.vaccine.2025.127907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。